CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


QuestionnairesWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (5)


Name (Synonyms) Correlation
drug428 Interferon Beta-1A Wiki 0.41
drug775 Standard of care Wiki 0.25
drug478 Lopinavir/ritonavir Wiki 0.22
drug691 Remdesivir Wiki 0.21
drug360 Hydroxychloroquine Wiki 0.09

Correlated MeSH Terms (6)


Name (Synonyms) Correlation
D020920 Dyssomnias NIH 0.50
D020447 Parasomnias NIH 0.50
D012893 Sleep Wake Disorders NIH 0.50
D014777 Virus Diseases NIH 0.08
D045169 Severe Acute Respiratory Syndrome NIH 0.05
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There are 2 clinical trials

Clinical Trials


1 COVID-19 and the Developement of Phobic Fears of Disease

A lot of people suffer from phobias. Phobias concerning certain diseases are not rare. This study will examine whether the COVID-19 (Coronavirus Disease) crisis was able to rise phobias in people and if those with preexisting phobias or fears were more likely to develop a phobia concerning COVID. It will look at different subtypes - doctors, medical personnel and general public (not medically affiliated).

NCT04359121 COVID19 Other: Questionnaires

Primary Outcomes

Description: assessed by questionnaire

Measure: Development of phobias

Time: 2 years

2 Sleep Quality During COVID-19 Containment in Children 7 to 12 Years Old, Whether or Not Usually Followed in Child Psychiatry

The purpose of this study is to determine whether sleep disturbances in children aged 7 to 12 during COVID-19 containment are more prevalent in children who received routine psychiatric care before containment compared to children who don't have any psychiatric care.

NCT04370210 Sleep Disturbance Behavioral: Questionnaires
MeSH:Dyssomnias Sleep Wake Disorders Parasomnias

Primary Outcomes

Description: Sleep quality is assessed in both groups with the Sleep Disturbance Scale for Children (SDSC scale). A score ≥ 45/125 is considered as pathological.

Measure: Comparison of sleep quality during COVID-19 containment between children usually followed in child psychiatry and children without follow-up

Time: An average of 1 day

Secondary Outcomes

Description: Child depression is measured using Child Depression Inventory Scale (CDI scale). For each item the score is graded by severity from 0 (normal behavior) to 2 (severe).

Measure: Assessment of child depression in both groups

Time: An average of 1 day

Description: Child anxiety is measured using Revised Children's Manifest Anxiety Scale (RCMAS). For each item, child answer by Yes or No. The total score is interpreted using the correspondence tables in function of sex and age

Measure: Assessment of child anxiety in both groups

Time: An average of 1 day

Description: Sleep quality is assessed with the Sleep Disturbance Scale for Children (SDSC scale). The score obtained is interpreted in function of socio-demographic factors (age, sex, lifestyle, couple status, profession and socio-professional category, education)

Measure: Assessment of the influence of socio-demographic factors on sleep in both groups

Time: An average of 1 day

Description: Sleep quality is assessed with the Sleep Disturbance Scale for Children (SDSC scale). For their parents, sleep quality and anxiety level are measured with a numerical scale between 0 and 10. For sleep quality, 0 correspond to a very poor quality and 10 to a very good quality. For anxiety level, 0 correspond to no anxiety and 10 to a severe anxiety. The score obtained for child is interpreted in function of their parents score.

Measure: Measure of the correlation between child sleep quality and parents sleep quality (anxiety level) in both groups

Time: An average of 1 day

Description: Sleep quality is assessed with the Sleep Disturbance Scale for Children (SDSC scale). The score obtained is interpreted in function of child psychiatry diagnoses coded with Diagnostic and Statistical Manual of Mental Disorders (DSM-5)

Measure: Assessment of sleep disturbance based on psychiatry diagnoses in the group of children usually followed in child psychiatry

Time: An average of 1 day

Description: Child anxiety is measured using Revised Children's Manifest Anxiety Scale (RCMAS). For each item, child answer by Yes or No. The score obtained is interpreted in function of child psychiatry diagnoses coded with Diagnostic and Statistical Manual of Mental Disorders (DSM-5)

Measure: Assessment of child anxiety based on psychiatry diagnoses in the group of children usually followed in child psychiatry

Time: An average of 1 day

Description: Child depression is measured using Child Depression Inventory Scale (CDI scale). For each item the score is graded by severity from 0 (normal behavior) to 2 (severe). The score obtained is interpreted in function of child psychiatry diagnoses coded with Diagnostic and Statistical Manual of Mental Disorders (DSM-5)

Measure: Assessment of child depression based on psychiatry diagnoses in the group of children usually followed in child psychiatry

Time: An average of 1 day


No related HPO nodes (Using clinical trials)